000 01717 a2200481 4500
005 20250516180746.0
264 0 _c20161213
008 201612s 0 0 eng d
022 _a1479-666X
024 7 _a10.1016/j.surge.2013.09.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTorrance, Andrew D W
245 0 0 _aHas integrated 18F FDG PET/CT improved staging, reduced early recurrence or increased survival in oesophageal cancer?
_h[electronic resource]
260 _bThe surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
_cFeb 2015
300 _a19-33 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aEsophageal Neoplasms
_xdiagnosis
650 0 4 _aEsophagectomy
650 0 4 _aFemale
650 0 4 _aFluorodeoxyglucose F18
_xpharmacology
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
_xepidemiology
650 0 4 _aNeoplasm Staging
650 0 4 _aPositron-Emission Tomography
_xmethods
650 0 4 _aPrognosis
650 0 4 _aRadiopharmaceuticals
_xpharmacology
650 0 4 _aRetrospective Studies
650 0 4 _aSurvival Rate
_xtrends
650 0 4 _aTomography, X-Ray Computed
_xmethods
650 0 4 _aUnited Kingdom
_xepidemiology
700 1 _aAlmond, L Max
700 1 _aFry, J
700 1 _aWadley, Martin S
700 1 _aLyburn, Iain D
773 0 _tThe surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
_gvol. 13
_gno. 1
_gp. 19-33
856 4 0 _uhttps://doi.org/10.1016/j.surge.2013.09.002
_zAvailable from publisher's website
999 _c23245529
_d23245529